We are part of the Orion Group
Orion Pharma (UK) Ltd. is a wholly owned subsidiary of Orion Corporation, which is a pharmaceutical company based in Finland and listed on the Nasdaq OMX Helsinki stock exchange. Orion Pharma (UK) Ltd was opened in Newbury in 1996 and is now based in Reading. Our principal role is to represent Orion's pharmaceutical products in the UK. Our focus is on Prescription Only Medicine (POM). The core therapy areas of Orion are neurological disorders, oncology and respiratory disease.
In the spirit of the values which are common to all units and employees of the Group, we endeavour to provide innovative medicinal treatments and best quality service to patients, healthcare professionals and the community in the UK, the region we operationally cover.
This local website of Orion Pharma concentrates on providing the regulatory information required to be accessible and available on the internet for UK patients and healthcare providers. For understanding more about the Orion Group, its businesses, products and operations, you are advised to visit www.orion.fi , the corporate website providing a plentiful package of up-to-date information about Orion Pharma.
MAY 2022 / CORP-208a(1)